Apoptosis and cell growth arrest in A375 human melanoma cells by diorganotin(IV) and triorganotin(IV) complexes of [meso-Tetra(4-sulfonatophenyl)porphine]manganese(III)chloride by Costa, M. et al.
Abstract. In previous studies we have demonstrated that two
derivatives of meso-Tetra(4-sulfonatophenyl)porphine
(TPPS), (Bu2Sn)2TPPS and (Bu3Sn)4TPPS, cause apoptotic
death of A375 melanoma cells and, at lower concentrations,
arrest of cell proliferation. In the present study, we examined
if the manganese metal inside the porphyrin cavity could
improve the efficacy of this class of compounds. Thus, [meso-
Tetra(4-sulfonatophenyl)porphine]Mn(III)Cl (=MnTPPS)
derivatives, namely (Me2Sn)2MnTPPS, (Bu2Sn)2MnTPPS,
(Me3Sn)4MnTPPS and (Bu3Sn)4MnTPPS, were tested on the
A375 human melanoma cell line. A cytotoxicity assay
showed that (Bu2Sn)2MnTPPS and (Bu3Sn)4MnTPPS were
highly cytotoxic by inducing apoptosis in melanoma cells, as
shown by DNA fragmentation analysis and by apoptotic
nuclei fluorescence, and when used at lower concentrations,
they affected only cellular proliferation. An arrest of cell
proliferation was also observed with (Me3Sn)4MnTPPS, but
at the highest concentrations used. Moreover, the lower
concentration of (Bu3Sn)4MnTPPS induced a change in cell
morphology, from a polygonal to an elongated and spindle-
shaped phenotype, likewise to its cognate (Bu3Sn)4TPPS,
previously tested. Western blotting analysis showed indeed
that both tributyltin compounds, i.e. (Bu3Sn)4MnTPPS and
(Bu3Sn)4TPPS, lowered levels of the major proteins involved
in tumorigenesis: ß-catenin, c-myc and snail. We also demon-
strated that all compounds entered the cells and localized in
the nuclei. In conclusion, our results show that, in spite of the
Mn(III) metal introduction, the butyl derivatives always have
a higher efficacy than methyl derivatives, and the tributyltin
compounds in particular have an interesting effect in vitro on
A375 cell proliferation.
Introduction
The study of porphyrin derivatives as potential anti-tumour
drugs has been an interesting field of investigation over the
last two decades. Porphyrins are a class of tetrapyrroles
which possess a highly-conjugated heterocyclic macrocycle
and, as a consequence, have very intense absorption in the
visible region and therefore are deeply coloured. Many
porphyrins occur in nature as a major component of key
functional molecules for biological activity, such as hemo-
globin, myoglobin, vitamin B12, chlorophyll and cytochromes.
For their inherent properties to localize tumour and to persist
there for long periods of time coupled with their ability to
generate reactive singlet oxygen, when activated by visible
light, porphyrins have been successfully used as photo-
sensitizers for photodynamic therapy (PDT) in the area of
oncology (1-4).
PDT is actually based on the selective uptake of a photo-
sensitizer that localizes to a specific tumour cell/tissue type,
followed by irradiation with light of the appropriate wavelength
to activate the sensitizer. Upon activation, the photosensitizer
forms an excited triplet state (via a singlet) which reacts with
molecular oxygen and other substrates to produce reactive
oxygen species (ROS) that cause the death of tumour cells
(1,5,6). While effective, the PDT with porphyrins has several
drawbacks, such as long-term skin photosensitivity and loss
of absorbance during irradiation due to rapid photobleaching
for the prolonged photosensitization entailed (2,7,8). In
particular, melanotic melanomas have a poor response to
PDT and the reason for this is that melanin absorbs the light
at the same wavelength region (400-750 nm) of porphyrins
absorption, thus lowering their effect (9,10). Moreover, even
if the porphyrin derivatives localize tumour melanocytes and
induce ROS production through PDT, melanoma cells are
able to survive and to go over the stress state (11,12).
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Melanoma is the most deadly form of skin cancer. If
melanoma is diagnosed early it can be cured by surgical
resection, and ~80% of cases are dealt with in this way.
Moreover, metastatic malignant melanoma is largely
refractory to existing therapies and has a very poor prognosis,
with a median survival rate of 6 months and 5-year survival
rate of <5%, thus new treatment strategies are urgently
needed (13).
For some years we have been studying the diorgano- and
triorganotin(IV) complexes of the meso-Tetra(4-sulfo-
natophenyl)porphine (TPPS) on A375 melanoma cells, a
highly invasive human cell line. As previously showed, these
compounds as well as other similar porphyrin derivatives
have a photo-independent cytotoxic effect (14-17). In fact,
we demonstrated that (Bu2Sn)2TPPS and (Bu3Sn)4TPPS
compounds induce the apoptotic death of A375 human
melanoma cells without being irradiated (18), causing an
arrest of cell proliferation as well, when used at lower
concentrations (19).
In order to be successful in finding more effective
compounds, we tested on A375 human melanoma cell line
the above-mentioned complexes but with a metal inside
porphyrin cavity. We studied diorgano- and triorganotin(IV)
complexes of meso-Tetra(4-sulfonatophenyl) porphine
containing Mn(III)Cl within the porphyrin ring (20), such
as (Me2Sn)2MnTPPS (MnTPPS1), (Bu2Sn)2MnTPPS
(MnTPPS2), (Me3Sn)4MnTPPS (MnTPPS3) and (Bu3Sn)4
MnTPPS (MnTPPS4), to investigate whether manganese
metal insertion enhances the effect of such compounds.
This paper presents the results obtained by treating A375
cells with the MnTPPS derivatives. We found that manga-
nese metal (MnIII) does not improve the effects of TPPS
organotin(IV) complexes. More remarkable, we demon-
strated that tributyltin complexes have an interesting effect
on A375 cell line by affecting the major proteins involved in
tumorigenesis.
Materials and methods
Chemicals and immunoreagents. Stock solutions (10-2 M) of
MnTPPS, MnTPPS1, MnTPPS3 in water and MnTPPS2,
MnTPPS4 in dimethylsulfoxide (DMSO) were prepared
immediately before their use, and then diluted in growth
medium. Total tin content was determined by a Perkin-Elmer
model 3100 atomic absorption spectrometer, equipped with
a Perkin Elmer mod. 100 flow injection analysis system
for atomic spectroscopy, according to standard procedure.
The solvent DMSO was a Merck (Darmstadt, Germany)
reagent.
Bisbenzimide H 33342 trihydrochloride (Hoechst), for
fluorescence, was from Sigma-Aldrich (St. Louis, MO, USA).
Anti-ß-catenin (clone 14) monoclonal antibody was purchased
from BD Transduction Laboratories (Lexington, KY, USA).
Rabbit polyclonal antibody that recognizes c-myc (N-262)
was purchased from Santa Cruz Biotechnology and anti-snail
(L70G2) monoclonal antibody from Cell Signaling Technology
(Beverly, MA, USA). Anti-·-tubulin is a mouse monoclonal
antibody purchased from Sigma (St. Louis, MO, USA).
HRP-conjugated anti-rabbit and anti-mouse antibodies were
purchased from GE Healthcare, Biosciences UK.
Cell culture. Human malignant melanoma A375 cell line
(ATCC-CRL-1619) (21) was a kind gift by Professor
Catherine Alcaide-Loridan and Dr Reem Al-Daccak. Cells
were cultured in RPMI supplemented with 10% FCS and 1%
penicillin-streptomycin (10,000 U/ml and 10,000 μg/ml,
respectively) in 5% CO2 at 37˚C.
Cell viability assay. Cell viability was evaluated by trypan
blue [0.5% (w/v), EuroClone], the most common stain used
to distinguish viable from non-viable cells. In brief, cells
were plated on 12-well plates at 1.5x105 cells/well in 1.5 ml
of growth medium. Cultures were incubated for 24 h after
which the appropriate concentrations of the test substances
were added in complete medium and incubated for 24, 48 or
72 h. MnTPPS was used at 10 μM (f.c.), while the other
substances at 10, 1 or 0.1 μM. The final concentration of
DMSO was 0.1% (v/v). Every treatment was renewed daily.
At the end of drug treatment, cells were recovered and a
small sample of each cell suspension was diluted 1:1 in
trypan blue and counted under normal light microscopy. The
percentage of viable cells was calculated using the following
formula:
Viable cells counted x 100
% Viability = ––––––––––––––––––––––
Total cells counted
DNA laddering. Cells were grown in 100-mm culture dishes
(2.5x106 cells/dish) for 24 h and then treated with 10 and
1 μM of MnTPPS2 or MnTPPS4 for further 24 h. Genomic
DNA was isolated from all (adherent and non-adherent)
treated cells, and 0.1% DMSO-treated cells were used as
control. In order to isolate the DNA we used the GenEluteTM
Mammalian Genomic DNA Miniprep Kit (Sigma-Aldrich).
Isolated DNA was electrophoresed in 2% agarose gel using
a voltage gradient gel (22) and photographic documenta-
tion was performed after staining with ethidium bromide at
0.5 ng/ml.
Nuclear morphology by fluorescence microscopy. Cells
(4x104 cells/well in 400 μl growth medium) were plated on
an 8-well Lab-Tek II chamber slide, cultured for 24 h and
then treated for 2 h with 1 μM MnTPPS2 or MnTPPS4. After
incubation, the medium was removed and wells were washed
twice with 400 μl of growth medium without serum. Cells were
fixed with 4% paraformaldehyde (f.c.) in PBS at room tempe-
rature for 20 min, rinsed twice with PBS and stained with
Hoechst 33342 fluorescent DNA-binding dye at 0.01 mg/ml
at room temperature for 10 min. After rinsing three times
with PBS, the chamber was removed and the slide sealed for
the microscopic inspection. The nuclear morphology was
observed using a DAPI filter (blue emission) for Hoechst on
a Zeiss Axioskop 2 Plus microscope, equipped for epifluo-
rescence and recorded by a digital camera system. 
Inverted microscope digital imaging. Cells (3x106 cells/dish)
were grown in 100-mm culture dishes for 24 h and then
treated for 24, 48 and 72 h with 0.1 μM MnTPPS4. The
corresponding amount of DMSO was added to the control
cells. The treatment and the culture medium were renewed
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daily. Photographs were taken after 48 h treatment by inverted
microscope (Motic type 101M) with x20 objective.
Fluorescence microscopy analysis. Cells (4x104 cells/well in
400 μl growth medium) were plated on an 8-well Lab-Tek II
chamber slide, cultured for 24 h and then treated with 160
μg/ml of each compound for 1 h. After incubation, cells were
fixed and nuclei stained with Hoechst as above reported.
Fluorescence images were obtained using a rhodamine filter
(red emission) to detect MnTPPS and its derivatives cellular
localization and a DAPI filter (blue emission) for Hoechst on
the Zeiss Axioskop 2 Plus microscope.
Subcellular fractionation. Cells (3x106 cells/dish) were grown
in 100-mm culture dishes for 24 h and then treated with
MnTPPS4 or TPPS4 at 0.1 μM, or 0.1% DMSO for 48 h. For
preparation of cytoplasmic and nuclear extracts, cells were
first swollen in hypotonic buffer (5 mM KC1, 1 mM MgC12,
20 mM HEPES pH 7.9 and 1 mM Na3VO4) containing an
antiprotease cocktail for 30 min on ice, then lysed with a tight-
fitting pestle of a Potter homogenizer (60 strokes). Nuclei
were separated by centrifugation at 1,000 x g for 10 min. The
supernatant was centrifuged at 100,000 x g for 30 min to
pellet the membrane fraction and yield the cytosolic fraction.
The nuclear pellet was washed three times in hypotonic
buffer containing 0.5% NP-40 and 0.25% sodium deoxycolate
and lysed in 10 mM HEPES pH 7.9, 0.4 M NaCl, 1.5 mM
MgCl2, 0.1 mM EGTA, 5% glycerol, 0.5% NP-40, 1 mM
Na3VO4 and protease inhibitors. The nuclear fraction was
centrifuged at 10,000 x g for 30 min to pellet debris. 
SDS/PAGE and Western blot analysis. Protein content of
cytosolic and nuclear extracts was determined by the Bio-
Rad protein assay (Bio-Rad laboratories GmbH, München,
Germany). SDS/PAGE was carried out on 10% polyacry-
lamide gels by method of Laemmli (23). Each protein sample
(50 μg) from subcellular fractionation was analyzed by
SDS-PAGE. Gels were either stained with Coomassie blue or
electroblotted onto PVDF-membranes (Millipore Corporation,
Bedford, MA, USA), saturated with 3% bovine serum albumin
(BSA) in PBS containing 0.1% Tween-20 and 0.02% NaN3
for 3 h at room temperature. Membranes were probed over-
night with the following antibodies: anti-ß-catenin (1:1,000),
anti-c-myc (1:500), anti-snail (1:1,000). After several
washes, the membranes were incubated for 1 h with either
HRP-conjugated anti-rabbit or HRP-conjugated anti-mouse
antibodies (1:5,000). Bound antibodies were detected using
an enhanced chemiluminescence kit (SuperSignal West Pico
Chemiluminescent Substrate, Pierce).
Results
MnTPPS2 and MnTPPS4 induce cell death in A375 human
melanoma cells. We examined the effects on A375 cell viabi-
lity of several new organotin(IV) derivatives of MnTPPS. We
used methyl derivatives, MnTPPS1 and MnTPPS3, and butyl
derivatives, MnTPPS2 and MnTPPS4, for our experiments.
The free MnTPPS ligand was used as a negative control.
A375 cells were treated for 24, 48 and 72 h with three
different concentrations (10, 1 and 0.1 μM) for each compound
and with 10 μM for MnTPPS ligand. Cell viability test by
trypan blue showed that MnTPPS2 and MnTPPS4 were
highly cytotoxic at 10 and 1 μM concentrations (Fig. 1B),
differently from MnTPPS1 and MnTPPS3 (Fig. 1A). 
Apoptosis of A375 cells identified by DNA fragmentation and
nuclei fluorescence. A biochemical hallmark of apoptosis is
the fragmentation of genomic DNA, in which the genome is
cleaved at internucleosomal sites, generating a typical ladder
pattern in DNA electrophoresis.
We isolated the genomic DNA after treating A375 cells
for 24 h with MnTPPS2 or with MnTPPS4 using the concen-
trations 10 and 1 μM for both substances. Since a certain
number of treated melanoma cells became detached, they were
rescued from the medium by gentle centrifugation. Afterwards,
pelleted cells were pooled with adherent ones and together
appropriately treated for DNA isolation and assessment. Both
substances induced a prominent DNA ladder formation both
at 10 and 1 μM concentration (Fig. 2A and B).
An early morphological event of the apoptosis is the
chromatin condensation that starts peripherally along the
nuclear membrane, forming a crescent or ring-like structure.
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Figure 1. Effects of MnTPPS derivatives on A375 human melanoma cell
viability. A375 cells were grown in 12-well plates (1.5x105 cells/well) for
24 h and then the appropriate concentrations of the substances to be tested
were added. Adherent and non-adherent cells were pooled after 24, 48 and
72 h treatment. Cell viability was determined by trypan blue assay. (-),
untreated cells in A and DMSO treated cells in B, as controls. Each data
represent the mean of cell death calculated from at least three separate
experiments, for which the standard error is indicated.
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During later stages, once DNA is cleaved into fragments of
regular size, the nucleus appears to be one or a group of
featureless, bright spherical beads. Hoechst 33342 is a type
of blue-fluorescence dye which stains the condensed chromatin
in apoptotic cells more brightly than normal chromatin. Thus,
we visualized the morphological features of apoptotic nuclei
by staining cells with Hoechst 33342, after 2 h of treatment
with 1 μM MnTPPS2 or MnTPPS4, respectively. As shown
in Fig. 3, the nuclei of treated cells exhibited changes chara-
cteristic of apoptosis (Fig. 3D and F), distinguishing them
from control cells which showed a less bright and homoge-
neous staining of nuclei (Fig. 3B). 
Growth behaviour of melanoma cells treated with MnTPPS
and its derivatives. The effects of MnTPPS, MnTPPS1,
MnTPPS2, MnTPPS3 and MnTPPS4 compounds on A375
cell proliferation were calculated by counting the number of
cells recovered from multi-well plates after 24, 48 and 72 h
of treatment with the appropriate concentrations. No effect
was observed on cell growth for the MnTPPS1 compound at
any concentration and in any time of treatment (Fig. 4A).
Otherwise, the MnTPPS3 compound, at the concentration of
10 μM and after 48 h of incubation, caused a proliferation
arrest with a decrease in cell number, which remained
unchanged up to 72 h (Fig. 4B). A significant slowdown of
cell growth was also found for this compound at the
concentration of 1 μM (Fig. 4B). Interestingly, the MnTPPS2
and MnTPPS4 compounds affected cell growth, when used
at a lower concentration (0.1 μM), as early as 24 h of
treatment, as shown in Fig. 4C. In particular, MnTPPS4 also
induced a morphological change of A375 cells; in fact, after
48 h of treatment the cells appeared elongated and spindle-
shaped (Fig. 5B). The cell morphology began to change at
24 h and remained to 72 h, after which time and without any
additional treatment, the cells began dying (data not shown). 
MnTPPS and its derivatives localize into the nucleus. The
cell localization of MnTPPS and of its methyl and butyl
derivatives in A375 human melanoma cells was characterized
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Figure 2. Induction of internucleosomal DNA fragmentation after 24 h
treatment of A375 melanoma cells with MnTPPS2 (A) or MnTPPS4 (B).
Cells were grown and treated as described in Materials and methods. DNA
was isolated from the adherent and non-adherent cell population and the
electrophoresis in 2% agarose gel revealed prominent DNA ladder forma-
tion after treatment with the above-mentioned substances. C, DMSO treated
cells as a control; M, 100 bp DNA ladder (A and B).
Figure 3. Nuclear morphology of A375 melanoma cells treated with MnTPPS2
or MnTPPS4. Cells were incubated with DMSO (A and B) as a control, with
MnTPPS2 (C and D) or with MnTPPS4 (E and F) for 2 h and nuclei were
observed after staining with fluorescent dye Hoechst 33342. Normaski images
(A, C and E) and fluorescence images (B, D and F). Nuclei with signs of
late apoptosis are enclosed within circles (D and F) (original magnification
x40).
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by using a conventional fluorescence microscope (Fig. 6). By
exploiting porphyrin fluorescence, cells were observed after
1 h of incubation with 160 μg/ml for each compound. To
detect fluorescence, twice the concentration was needed
compared with compounds without manganese (18), most
likely owing to the decline of the fluorescence intensity due
to the metal insertion (24,25). As shown in Fig. 6 (B, E, H,
K and N), all the compounds entered into the cells and
concentrated in the nuclei, which were stained in blue with
Hoechst 33342 (Fig. 6C, F, I, L and O). 
MnTPPS4 and TPPS4 induce a decrease in ß-catenin, c-myc
and snail protein levels. The proliferation arrest and the
morphology cell change induced by MnTPPS4 in A375
human melanoma cells, as well as by its cognate without
manganese(III) chloride, the TPPS4 (19), led us to examine
the effects of both tributyltin compounds on proteins primarily
involved in these processes, such as ß-catenin, c-myc and
snail, constitutively overexpressed in human melanoma cells
(26-28).
A375 cells were treated for 48 h with 0.1% DMSO, as a
negative control, 0.1 μM MnTPPS4 or 0.08 μM TPPS4. The
cytosolic and nuclear fractions were prepared and analysed
by Coomassie blue-staining of SDS/PAGE (Fig. 7A and C).
By Western blotting, we analysed the protein expression
levels of ß-catenin, c-myc and snail (Fig. 7B and D). Interes-
tingly, we observed a clear reduction of cytoplasmic ß-
catenin in melanoma cells treated with MnTPPS4 (Fig. 7B)
or with TPPS4 (Fig. 7D), and a slight decrease of ß-catenin
can be also appreciated in the nuclei (Fig. 7B and D).
Moreover, a prominent decrease of nuclear c-myc and snail
proteins was found in both treatments, as shown in Fig. 7B
and D. 
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Figure 4. Effects of MnTPPS derivatives on A375 cell proliferation. Cells
were treated with the indicated concentrations for each MnTPPS derivative
for 24, 48 and 72 h. Curves show data obtained with MnTPPS (A and B);
MnTPPS1 (A); MnTPPS3 (B); MnTPPS2 and MnTPPS4 (C). The incu-
bation medium containing drug was changed daily. Control, untreated cells
(A and B), and cells treated with DMSO (C). Cell number was evaluated by
trypan blue exclusion test at the end of treatment. Error bars represent the
standard deviation of three separate experiments.
Figure 5. MnTPPS4-induced A375 cellular morphology change. Images of
living A375 cells incubated with DMSO (A) or with MnTPPS4 (B) for 48 h
(original magnification x20).
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Discussion
Cutaneous malignant melanoma is the most aggressive form
of skin cancer and survival remains very poor once the disease
has spread to distant sites. Until now, the only drug approved
by the Food and Drug Administration (FAD) for treating
metastatic melanoma is the alkylating agent dacarbazine
(DTIC), which results in clinical response only of 5-10% of
cases when given as a single agent (29). The notorious chemo-
resistance of melanoma cells, in contrast to other cancer
cells, seems not to be acquired selectively as a consequence
of drug therapy, but to be more intrinsic in melanoma cells.
Alteration of survival capacity and inactivation of apoptotic
pathways are the molecular mechanisms responsible of
conventional drug resistance in melanoma cells (30).
Accordingly, new drugs need to be studied in order to defeat
melanoma drug resistance.
Organometallic compounds have been gaining growing
importance in oncology, especially tin-derivatives that,
together with gold-, are enjoying an increasing interest and
appear very promising as potential drugs (31). Those investi-
gated by us in early (18,19) and in the present studies have
the peculiarity to contain the organometallic moieties bonded
to the oxygen atoms of the side chain sulfonatophenyl groups
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Figure 6. Localization of MnTPPS derivatives in A375 cells. Normaski images (A, D, G, J, M); fluorescence images by porphiryn derivatives (B, E, H, K, N);
fluorescence images by Hoechst stain (C, F, I, L, O). Cells were incubated for 1 h with MnTPPS (A, B, C), MnTPPS1 (D, E, F), MnTPPS3 (G, H, I),
MnTPPS2 (J, K, L) and MnTPPS4 (M, N, O) (original magnification x40).
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of a porphyrin ring. Porphyrins are well-known to have a
clear tendency to localize tumour by means of low-density
lipoproteins (LDL), whose specific receptors are highly
expressed in many types of transformed cells (32).
In the present study, diorgano- and triorganotin(IV)
[meso-Tetra(4-sulfonatophenyl)porphinate] derivatives with
Mn(III) metal bonded to nitrogen atoms of porphyrin ring
were analysed to evaluate whether manganese metal insertion
could improve their effect on the cell line tested. The results
show that, regardless of presence or absence of Mn(III), the
butyltin complexes have a higher efficacy than methyltin. In
fact, only the butyl-MnTPPS derivatives induce the apoptosis
showing to be still effective at the lower concentrations at
which they affect the growth of A375 cells. Moreover,
among the butyltin complexes, a stronger and interesting
effect of tributyltin (MnTPPS4) is evident compared with
dibutyltin (MnTPPS2), in agreement with what previously
reported by us (18,19) and others (31).
In our opinion, apart from Mn(III), the effects that tribu-
tyltin complexes have on A375 cell line is very intriguing. In
fact, focusing our attention on two tributyltin complexes, the
MnTPPS4 and the TPPS4, we found that both reduce protein
levels of ß-catenin, c-myc and snail, all of them known to
be involved in tumorigenesis (33-35) and in melanoma
progression (36-38).
Wnt/ß-catenin signalling pathway is crucial during various
stages of embryonic development and leads to tumour
formation when aberrantly activated. The activation of this
pathway inhibits ß-catenin degradation that results in its
accumulation in the nucleus, where it activates a variety of
target genes that contribute to cancer progression including
Myc (39).
A sinister role in tumour progression is also played by the
epithelial-to-mesenchymal transition (EMT), an important
development programme by which cells switch from a
polarized epithelial phenotype to a highly motile mesen-
chymal phenotype. If this mechanism is stimulated within the
adult organism, it promotes pathological conditions or
tumour metastasis (40). Members of the Snail family have
been shown to induce EMT, and c-myc seems also to be
involved in this process (35,41). Moreover, in transformed
epithelial cells it has been found that EMT correlates with the
presence of ß-catenin in the nucleus (42). Thereby, a resto-
ration of the mesenchymal-to-epithelial transition (MET)
programme should efficiently slow down the dedifferenti-
ation and dissemination of tumour cells. There is a growing
opinion that one of the future perspectives in anti-cancer
therapy would be to block these proteins. Therefore, the
morphological change of A375 from a polygonal shape
phenotype with numerous protrusions, distinctive of cancer
cells highly metastatic (43), to one elongated and spindle-
shaped, as a consequence of MnTPPS4 or TPPS4 treatment
(19), could be indicative of a less proliferative and differ-
entiated phenotype.
Taken together, these data suggest that A375 cells could
undergo a cell reprogramming, as shown by decreased expres-
sion of ß-catenin, c-myc and snail proteins, and an induction
of differentiation, as suggested by the cell proliferation arrest
and the changes in cell morphology. Thus, an attractive
hypothesis could be that the tributyltin (sulfonatophenyl)
porphinates have the potential to induce the differentiation of
neoplastic cells under appropriate concentrations, providing a
useful tool for the treatment of cancer. However, further
studies are required to understand the exact nature of the
biological action of tributyltin compounds, by studying the
cellular responses to this treatment also in other tumour cells
than the A375 melanoma cells.
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Figure 7. MnTPPS4 and TPPS4 reduce ß-catenin, c-myc and snail levels in
A375 cells. Cells were treated for 48 h with DMSO as a control, with
MnTPPS4 or with TPPS4, and cytosolic and nuclear fractions were prepared,
as described in Materials and methods. Protein samples were analysed by
SDS/polyacrylamide gel stained with Coomassie blue (A and C) or by
Western blotting with anti-ß-catenin, anti-c-myc and anti-snail (B and D)
antibodies. Equal protein loading was confirmed by gel staining (A and C).
Purity of nuclear fractions was confirmed by reaction with ·-tubulin antibody
(B and D). The results are representative of three independent experiments.
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